06 Jun 12
Isogenica, Cresset and Biolauncher Secure £1M Funding to Develop New Small Molecule Drug Platform
30 May 12
“Need a degree to get a pay rise – don’t bother if you’re 61 or older!”
“Want to work beyond the age of 65 – afraid not, it’s in our Partnership Deed!”
These may sound like the worst job adverts in the world, but in fact they are the subject matter of two cases whose judgments were handed down by the Supreme Court last week (25 April 2012). These key cases are set to challenge employer’s attitude to age and retirement.
28 May 12
There has never been so much data in the world as there is now - how can pharmaceutical companies make sense of these increasing volumes of data, both for marketing and regulatory purposes? Stephen Dunnigan of business intelligence firm MicroStrategy looks at how technology can help unlock the potential of big data.
24 May 12
As both social media and webcasting continue to evolve at a rapid rate the pharmaceutical sector continues to innovate and evolve the ways in which it communicates to diverse and geographically spread audiences.
Jake Ward, Business Development Director, Groovy Gecko
22 May 12
Oncology products dominate the global therapeutics market, and are on course to reach an estimated €56 billion in sales by 2015. While cultural differences in approaches to
treatment and research into cancer undoubtedly exist between countries, investigators throughout the European Union have adopted similar approaches to the rigorous
evaluations of novel oncology treatments in Phase I clinical trials. But such trials are not conducted without reference to a number of considerations.
Jane Bentley, Ph.D., Vice President, Oncology Division, Novella Clinical
22 May 12
In a fast growing healthcare sector- healthcare HR has to answer to critical demands that other industries do not face. From complying with very tight government regulation and processes to the need to ensure staff competence, more and more healthcare organizations are implementing talent management and workforce planning solutions to answer to the ever-increasing demands of the field
21 May 12
Gone are the days of highly customized, heavy footprint technologies with complex, over-engineered work streams. The Regulatory industry is looking for a kinder, gentler solution that doesn’t require teams of support personnel to install and validate a software update.
Monique Garrett, Vice President, Global Strategy
15 May 12
Until 1st October 2011, most businesses adopted the default National Retirement Age (NRA) of 65 for their staff. Under the then law, employers had the right to retire employees at 65, provided they followed the statutory retirement procedures.
Marc Jones, Employment Partner, Turbervilles Solicitors
11 May 12
If you are a person who has a knack for convincing others to follow your lead and you have a special curiosity in the sciences, you could be the perfect candidate for a career in pharmaceutical sales. A positive, proactive attitude and a fierce determination to succeed are all important qualities in pharmaceutical sales.
11 May 12
Pharmaceutical brand managers have the task of bringing success to a brand's lifecycle. Every brand has this lifecycle – where it is introduced to the market before it eventually 'dies' out. People who work in this role will want to make that brand as successful as possible while extending its lifecycle as much as they can to get more profits out of the drug.
09 May 12
Health economics is one of those rapidly growing fields that links up business with health care. A health economist has a unique passion for using their knowledge of economics by applying it to a variety of challenges in health and medicine. As the population continues to grow, the demand for quality and cost-effective health care similarly grows, leaving careers in health economics vital to sustaining our health care system
01 May 12
Medimetrics, recently certified to ISO 13485, has successfully developed the IntelliCap system, specifically designed to target delivery of small molecule drugs and biologics to the GI tract. The technology is capable of achieving controlled release of drugs to specific GI sites in a fast, cost-effective and convenient manner (Shimizu et al., 2008).
10 Apr 12
Why is Facebook on its way to become a $100 billion dollar enterprise? Because, the corporate world is very comfortable with ‘predictability driven marketing’ surrounded by ‘search based social mediums’ expects ‘click based’ returns on investments and believes in 247/365 multidirectional expansion while rest of the world loves the freedom to engage online.
28 Mar 12
If you want to go further in your clinical research career, the Institute of Clinical Research (ICR) can help. We provide training, analysis and discussion of the issues facing clinical research today, and opportunities for widening your professional network. Join ICR today, and benefit from all these resources straight away, many of them at specially discounted rates.
28 Mar 12
Strontium ranelate (Protelos ®) reduced structural progression of osteoarthritis (OA) in knee joints by one third, finds an international phase III study. The trial, presented at the European Congress of Osteoporosis and Osteoarthritis (IOF-ECCEO) meeting in Bordeaux, France, 21 to 24 March, 2012, is the first study ever to have demonstrated a disease modifying effect in OA, with additional benefits shown for pain, function and mobility.
14 Mar 12
Financial and budgetary, IT and green skills top the list of ten skills that Hays’ global offices and clients commonly identify as being in greatest demand.
“Talent shortages are a global problem,” said Simon Lance, Regional Director of Hays in China. “We operate in 31 countries and these skills are the ones that our clients globally say are in most demand. For anyone considering their career options in our globalised economy, these are the skills to focus on.
Kathy Lou, Marketing Manager of Hays in China
27 Feb 12
This year is another bumper year for employment law changes. In this article we consider the key changes for employers in 2012, planned changes to Employment Tribunal practice and procedure and what changes are still in the pipeline.
16 Feb 12
Suddenly, perfect storms are developing on the global branding fronts; the top of the agenda is now ‘naming’ of the brands itself and how will the names survive the rapid changes of massive digitalization of social media where such name identities reside and skate to catch customers via global cyber branding.
15 Feb 12
Ordering, management and workflow efficiency to be optimized using industry-favored software solution
27 Jan 12
The boardroom agendas must raise some of these questions. What are the specific tactical options available for the organization at this stage? What are the hot buttons on name evaluation for national or global cyber name branding? What are the key steps to get current name identity ahead of competitors on fast track basis? What are the new digital platforms for mass-customer-acquisition? What are the methodical steps to market domination via name identity?
20 Jan 12
Recruiters are very busy people, and typically have little time to read and select CVs for any given role. For them it’s a filtering process, often starting with a pile of CV’s and throwing out the bad ones before reading in more detail, the ones that are left. Therefore your task is NOT to get thrown out with the bathwater, and ensure that your CV is one of the ones that makes it past the first cull!
21 Dec 11
The integration of mobile technology, bilingual skills and the use of Recruitment Process Outsourcing for global expansion are amongst the top issues that will dominate China’s recruitment market in 2012, according to recruiting experts Hays.
Kathy Lou Marketing Manager, China HAYS Recruiting expert worldwide
21 Dec 11
Building a team of suitably qualified clinical research professionals within the Asia Pacific region, particularly in China, South Korea, Taiwan and India, has become a critical requirement due to the enormous growth in clinical trial activity in the region.
Paula Mumby, Vice President, Operations, Asia Pacific
09 Dec 11
It is estimated that long term sickness absence costs the UK economy almost £9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.